P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope

Autor: Dwek R, Burton D, Smith D, Zitzmann N, Doores K, Mansab F, Dunlop DC, Scanlan C

Publikováno v: Retrovirology, Vol 6, Iss Suppl 3, p P87 (2009)

Externí odkaz: https://doaj.org/article/9dc550606e2747adac6716ef50c188b0

Insulin-dependent diabetic pregnancy and driving: is the correct advice being given? A telephone survey.

Autor: Dunlop DC, Kelly LC, Dunster GD, O'Hare JP

Publikováno v: Practical Diabetes International; 1997 Jan-Feb, Vol. 14 Issue 1, p12-13, 2p

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Autor: Pritchard LK; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Spencer DI; Ludger Ltd., Culham Science Centre, Abingdon, Oxfordshire OX14 3EB, UK., Royle L; Ludger Ltd., Culham Science Centre, Abingdon, Oxfordshire OX14 3EB, UK., Bonomelli C; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Seabright GE; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Behrens AJ; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Kulp DW; 1] Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA [2] Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California 92037, USA., Menis S; 1] Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA [2] Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California 92037, USA., Krumm SA; King's College London School of Medicine at Guy's, King's and St Thomas' Hospitals, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Dunlop DC; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Crispin DJ; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Bowden TA; Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK., Scanlan CN; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK., Ward AB; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA., Schief WR; 1] Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037, USA [2] Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California 92037, USA [3] Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts 02139, USA., Doores KJ; King's College London School of Medicine at Guy's, King's and St Thomas' Hospitals, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Crispin M; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.

Publikováno v: Nature communications [Nat Commun] 2015 Jun 24; Vol. 6, pp. 7479. Date of Electronic Publication: 2015 Jun 24.

IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

Autor: Nilvebrant J; School of Biotechnology; Department of Proteomics; Royal Institute of Technology (KTH); AlbaNova University Center; Stockholm, Sweden., Dunlop DC; The Scripps Research Institute; La Jolla, CA USA., Sircar A; EMD Serono Research Institute; Billlerica, MA USA., Wurch T; Oncology Research Division, Institut de Recherche SERVIER; Croissy sur Seine, France., Falkowska E; The Scripps Research Institute; La Jolla, CA USA., Reichert JM; Landes Bioscience; Austin, TX USA., Helguera G; Farmacotecnia I, Facultad de Farmacia y Bioquímica; University of Buenos Aires; Ciudad Autónoma de Buenos Aires, Argentina., Piccione EC; Standford Cancer Institute; Stanford University School of Medicine; Stanford, CA USA., Brack S; Covagen AG; Zürich Schlieren, Switzerland., Berger S; Institut de Recherche Pierre Fabre, Centre d'Immunologie Pierre Fabre; St Julien en Genevois, France.

Publikováno v: MAbs [MAbs] 2012 Mar-Apr; Vol. 4 (2), pp. 153-81. Date of Electronic Publication: 2012 Mar 01.

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Autor: Burton DR; Department of Immunology and Microbial Science and International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA. burton@scripps.edu, Hessell AJ, Keele BF, Klasse PJ, Ketas TA, Moldt B, Dunlop DC, Poignard P, Doyle LA, Cavacini L, Veazey RS, Moore JP

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2011 Jul 05; Vol. 108 (27), pp. 11181-6. Date of Electronic Publication: 2011 Jun 20.